Home>
US Stocks>
Pacific Biosciences Of California

Pacific Biosciences Of California share price today

(PACB)

Pacific Biosciences Of California share price is $1.97 & ₹167.40 as on 21 Dec 2024, 2.30 'hrs' IST

$1.97

▲

0.04

(2.07%)

Market is closed - opens 8 PM, 23 Dec 2024

View live Pacific Biosciences Of California share price in Dollar and Rupees. Guide to invest in Pacific Biosciences Of California from India. Also see the sentimental analysis on Indian investors investing in Pacific Biosciences Of California. Get details on the Indian mutual funds that are investing in Pacific Biosciences Of California. Get Analyst recommendations and forecasts along with all the Pacific Biosciences Of California's financials.

Pacific Biosciences Of California share price movements

Today's Low: $1.86
Today's High: $2.01
$1.97
5.76%
Downside
Day's Volatility :7.41%
Upside
1.75%
52 Weeks Low: $1.16
52 Weeks High: $10.65
$1.97
41.12%
Downside
52 Weeks Volatility :89.11%
Upside
81.5%

Pacific Biosciences Of California Returns

Period	Pacific Biosciences Of California, Inc.	Sector (Health Care)	Index (Russel 2000)
3 Months	13.22%	-11.1%	0.0%
6 Months	35.86%	-6.0%	0.0%
1 Year	-80.44%	2.7%	0.0%
3 Years	-90.94%	0.6%	-19.7%

Pacific Biosciences Of California Key Statistics

in dollars & INR

Previous Close	$1.93
Open	$1.87
Today's High	$2.005
Today's Low	$1.8565
Market Capitalization	$568.0M
Today's Volume	$10.2M
52 Week High	$10.65
52 Week Low	$1.16
Revenue TTM	$173.1M
EBITDA	$-242.9M
Earnings Per Share (EPS)	$-1.46
Profit Margin	-227.69%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-64.8%

How to invest in Pacific Biosciences Of California from India?

It is very easy for Indian residents to invest directly in Pacific Biosciences Of California from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Pacific Biosciences Of California stock in both Indian Rupees (INR) and US Dollars (USD). Search for Pacific Biosciences Of California or PACB on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Pacific Biosciences Of California or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Pacific Biosciences Of California shares which would translate to 0.431 fractional shares of Pacific Biosciences Of California as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India , including recognised companies like Pacific Biosciences Of California, in just a few clicks!

Returns in Pacific Biosciences Of California for Indian investors in Rupees

Investment Value

₹1,00,000

Pacific Biosciences Of California investment value today

Current value as on today

₹1,82,633

Returns

₹82,633

(+82.63%)

Returns from Pacific Biosciences Of California Stock

₹80,437 (false-80.44%)

Dollar Returns

₹2,196 (+2.2%)

Indian investors sentiment towards Pacific Biosciences Of California

-6.55%

Period: Sep 21, 2024 to Dec 20, 2024. Change in 30 Days versus previous period

Investment in Pacific Biosciences Of California from India has reduced in the last 30 days as on Dec 21, 2024. -6.55% less purchase transactions for Pacific Biosciences Of California in the last 30 days versus the previous period.

-2%

Period: Sep 21, 2024 to Dec 20, 2024. Change in 30 Days versus previous period

Search volume for Pacific Biosciences Of California on INDmoney from India has reduced in the last 30 days as on Dec 21, 2024. -2% less investors are searching Pacific Biosciences Of California in the last 30 days versus the previous period.

Global Institutional Holdings in Pacific Biosciences Of California

ARK Investment Management LLC
11.35%
BlackRock Inc
8.02%
Madrone Advisors LLC
7.95%
Edmond de Rothschild Holding S.A.
6.90%
Vanguard Group Inc
5.99%
Sumitomo Mitsui Trust Group Inc
4.03%

Analyst Recommendation on Pacific Biosciences Of California

Buy

55%Buy

45%Hold

0%Sell

Based on 20 Wall street analysts offering stock ratings for Pacific Biosciences Of California(by analysts ranked 0 to 5 stars)

Based on 20 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Pacific Biosciences Of California

What analysts predicted

Upside of 53.34%

Current:

$1.97

Target:

$3.02

Insights on Pacific Biosciences Of California

Price Movement
In the last 1 year, PACB stock has moved down by -80.1%
Increasing Revenue
Revenue is up for the last 2 quarters, 36.01M → 39.96M (in $), with an average increase of 9.9% per quarter
Increasing Net Profit
Netprofit is up for the last 2 quarters, -173.31M → -60.72M (in $), with an average increase of 185.4% per quarter
PACB vs BSX (1 yr)
In the last 1 year, Boston Scientific Corp. has given 59.8% return, outperforming this stock by 139.9%
PACB vs BSX (3 yr)
In the last 3 years, Boston Scientific Corp. has given 116.4% return, outperforming this stock by 207.3%
Price to Sales
ForPACB every $1 of sales, investors are willing to pay $3.1, whereas for Boston Scientific Corp., the investors are paying $8.2 for every $1 of sales.

Pacific Biosciences Of California Financials in INR & Dollars

	FY18	Y/Y Change
Revenue	$78.6M	↓ 15.88%
Net Income	$-102.6M	↑ 11.25%
Net Profit Margin	-130.44%	↓ 31.81%

	FY19	Y/Y Change
Revenue	$90.9M	↑ 15.6%
Net Income	$-77.8M	↓ 24.12%
Net Profit Margin	-85.62%	↑ 44.82%

	FY20	Y/Y Change
Revenue	$78.9M	↓ 13.2%
Net Income	$29.4M	↓ 137.78%
Net Profit Margin	37.27%	↑ 122.89%

	FY21	Y/Y Change
Revenue	$130.5M	↑ 65.43%
Net Income	$-181.2M	↓ 716.34%
Net Profit Margin	-138.85%	↓ 176.12%

	FY22	Y/Y Change
Revenue	$128.3M	↓ 1.69%
Net Income	$-296.9M	↑ 63.85%
Net Profit Margin	-231.43%	↓ 92.58%

	FY23	Y/Y Change
Revenue	$200.5M	↑ 56.29%
Net Income	$-306.7M	↑ 3.3%
Net Profit Margin	-152.97%	↑ 78.46%

	Q2 FY23	Q/Q Change
Revenue	$47.6M	↑ 22.3%
Net Income	$-69.8M	↓ 13.94%
Net Profit Margin	-146.79%	↑ 61.82%

	Q3 FY23	Q/Q Change
Revenue	$55.7M	↑ 17.06%
Net Income	$-66.9M	↓ 4.24%
Net Profit Margin	-120.07%	↑ 26.72%

	Q4 FY23	Q/Q Change
Revenue	$58.4M	↑ 4.79%
Net Income	$-82.0M	↑ 22.65%
Net Profit Margin	-140.55%	↓ 20.48%

	Q1 FY24	Q/Q Change
Revenue	$38.8M	↓ 33.5%
Net Income	$-78.2M	↓ 4.68%
Net Profit Margin	-201.44%	↓ 60.89%

	Q2 FY24	Q/Q Change
Revenue	$36.0M	↓ 7.21%
Net Income	$-173.3M	↑ 121.7%
Net Profit Margin	-481.27%	↓ 279.83%

	Q3 FY24	Q/Q Change
Revenue	$40.0M	↑ 10.98%
Net Income	$-60.7M	↓ 64.96%
Net Profit Margin	-151.94%	↑ 329.33%

	FY18	Y/Y Change
Profit	$25.1M	↓ 27.59%

	FY19	Y/Y Change
Profit	$34.6M	↑ 37.77%

	FY20	Y/Y Change
Profit	$32.6M	↓ 5.81%

	FY21	Y/Y Change
Profit	$58.9M	↑ 80.74%

	FY22	Y/Y Change
Profit	$49.0M	↓ 16.69%

	FY23	Y/Y Change
Profit	$52.8M	↑ 7.64%

	Q2 FY23	Q/Q Change
Profit	$15.5M	↑ 59.27%

	Q3 FY23	Q/Q Change
Profit	$17.9M	↑ 15.16%

	Q4 FY23	Q/Q Change
Profit	$11.0M	↓ 38.53%

	Q1 FY24	Q/Q Change
Profit	$4.4M	↓ 59.75%

	Q2 FY24	Q/Q Change
Profit	$5.9M	↑ 34.07%

	Q3 FY24	Q/Q Change
Profit	$10.0M	↑ 68.47%

	FY18	Y/Y Change
Operating Cash Flow	$-66.4M	↓ 1.61%
Investing Cash Flow	$-38.4M	↑ 2379.99%
Financing Cash Flow	$107.2M	↑ 55.77%

	FY19	Y/Y Change
Operating Cash Flow	$-78.3M	↑ 17.89%
Investing Cash Flow	$62.0M	↓ 261.52%
Financing Cash Flow	$26.5M	↓ 75.23%

	FY20	Y/Y Change
Operating Cash Flow	$19.5M	↓ 124.9%
Investing Cash Flow	$-219.3M	↓ 453.48%
Financing Cash Flow	$251.8M	↑ 848.62%

	FY21	Y/Y Change
Operating Cash Flow	$-111.2M	↓ 670.07%
Investing Cash Flow	$-678.5M	↑ 209.38%
Financing Cash Flow	$1.2B	↑ 364.42%

	FY22	Y/Y Change
Operating Cash Flow	$-263.2M	↑ 136.74%
Investing Cash Flow	$116.1M	↓ 117.11%
Financing Cash Flow	$9.6M	↓ 99.18%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$-41.7M	↓ 55.92%
Investing Cash Flow	$-98.6M	↑ 35.89%
Financing Cash Flow	$-4.7M	↓ 102.41%

Pacific Biosciences Of California Technicals Summary

Sell

Neutral

Buy

Pacific Biosciences Of California is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Pacific Biosciences Of California Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Pacific Biosciences Of California, Inc.	11.3%	35.86%	-80.44%	-90.94%	-62.48%
Stryker Corporation	-6.55%	7.53%	22.55%	38.08%	71.54%
Boston Scientific Corp.	-2.79%	15.96%	59.12%	110.98%	96.7%
Edwards Lifesciences Corp.	6.29%	-17.03%	-1.35%	-41.48%	-5.43%
Abbott Laboratories	-2.58%	8.48%	4.77%	-17.81%	30.77%
Medtronic Plc	-4.38%	-0.01%	-1.09%	-20.04%	-28.85%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Pacific Biosciences Of California, Inc.	NA	NA	-0.17	-0.81	-0.65	-0.11	NA	1.66
Stryker Corporation	38.32	38.32	2.51	12.06	0.19	0.07	0.01	52.86
Boston Scientific Corp.	73.27	73.27	1.61	2.46	0.09	0.05	NA	14.05
Edwards Lifesciences Corp.	28.88	28.88	6.79	2.55	0.19	0.11	NA	16.18
Abbott Laboratories	34.17	34.17	2.17	4.68	0.15	0.06	0.02	22.94
Medtronic Plc	24.46	24.46	1.46	5.2	0.08	0.04	0.03	38.29

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Pacific Biosciences Of California, Inc.	Buy	$568.0M	-62.48%	NA	-227.69%
Stryker Corporation	Buy	$136.1B	71.54%	38.32	16.34%
Boston Scientific Corp.	Buy	$130.7B	96.7%	73.27	11.26%
Edwards Lifesciences Corp.	Buy	$44.1B	-5.43%	28.88	65.86%
Abbott Laboratories	Buy	$195.0B	30.77%	34.17	13.99%
Medtronic Plc	Buy	$102.6B	-28.85%	24.46	12.06%

About Pacific Biosciences Of California

pacbio develops comprehensive solutions for scientists that propel the field of genomics, improve science and research, and create positive impact globally. we provide sophisticated genomic analysis systems that deliver invaluable insights for scientists who strive to resolve complex genetic challenges. our strength comes from the dedication of our people, who are fueled by a desire to effect real, positive change. with a focus on the future and an experienced, passionate team, we are motivated to continue to redefine what is possible in genomics.

Organization	Pacific Biosciences Of California
Employees	796
CEO	Mr. Christian O. Henry M.B.A.
Industry	Health Technology

Management People of Pacific Biosciences Of California

Name	Title
Mr. Christian O. Henry M.B.A.	President, CEO, Interim CFO & Director
Mr. Mark Van Oene Ph.D.	Chief Operating Officer
Dr. Stephen Turner Ph.D.	Co-Founder
Ms. Michele Farmer CPA	VP & Chief Accounting Officer
Dr. Brett Atkins J.D., Ph.D.	General Counsel & Corporate Secretary
Ms. Natalie Welch	Chief People Officer

Important FAQs about investing in Pacific Biosciences Of California from India :

What is Pacific Biosciences Of California share price today?

Pacific Biosciences Of California share price today stands at $1.97, Open: $1.87 ; Previous Close: $1.93 ; High: $2.01 ; Low: $1.86 ; 52 Week High: $10.65 ; 52 Week Low: $1.16. The stock opens at $1.87, after a previous close of $1.93. The stock reached a daily high of $2.01 and a low of $1.86, with a 52-week high of $10.65 and a 52-week low of $1.16.

Can Indians buy Pacific Biosciences Of California shares?

Yes, Indians can invest in the Pacific Biosciences Of California (PACB) from India.

With INDmoney, you can buy Pacific Biosciences Of California at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Pacific Biosciences Of California at zero transaction cost.

How can I buy Pacific Biosciences Of California shares from India?

It is very easy to buy Pacific Biosciences Of California from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Pacific Biosciences Of California be purchased?

Yes, you can buy fractional shares of Pacific Biosciences Of California with INDmoney app.

What are the documents required to start investing in Pacific Biosciences Of California stocks?

To start investing in Pacific Biosciences Of California, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.